サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1609660

日本の医薬品ろ過市場レポート：製品、技法、用途、事業規模、地域別、2024年～2032年

Japan Pharmaceutical Filtration Market Report by Product, Technique, Application, Scale of Operation, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 120 Pages
納期
5～7営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
日本の医薬品ろ過市場レポート：製品、技法、用途、事業規模、地域別、2024年～2032年
出版日: 2024年12月05日
発行: IMARC
ページ情報: 英文 120 Pages
納期: 5～7営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

日本の医薬品ろ過市場の市場規模は2023年に7億2,080万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに23億8,830万米ドルに達し、2024年から2032年の間に12.70%の成長率（CAGR）を示すと予測しています。医薬品製造における純度を確保するための政府機関による厳格な規制の実施が、主に市場成長の原動力となっています。

本レポートで扱う主な質問

  • 日本の医薬品ろ過市場はこれまでどのように推移し、今後どのように推移するのか？
  • COVID-19が日本の医薬品ろ過市場に与えた影響は？
  • 日本の医薬品ろ過市場の製品別構成比は？
  • 日本の医薬品ろ過市場の技術別構成比は？
  • 日本の医薬品ろ過市場の用途別内訳は？
  • 日本の医薬品ろ過市場の事業規模別の内訳は？
  • 日本の医薬品ろ過市場のバリューチェーンにはどのような段階がありますか？
  • 日本の医薬品ろ過における主な促進要因と課題は何ですか？
  • 日本の医薬品ろ過市場の構造と主要プレーヤーは？
  • 日本の医薬品ろ過市場における競合の程度は？

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
  • 市場推定
  • 調査手法

第3章 エグゼクティブサマリー

第4章 日本の医薬品ろ過市場：イントロダクション

  • 概要
  • 市場力学
  • 業界動向
  • 競合情報

第5章 日本の医薬品ろ過市場情勢

  • 過去および現在の市場動向（2018～2023年）
  • 市場予測（2024～2032年）

第6章 日本の医薬品ろ過市場：製品別内訳

  • メンブレンフィルター
  • プレフィルターと深度メディア
  • 使い捨てシステム
  • カートリッジとカプセル
  • フィルターホルダー
  • 濾過アクセサリ
  • その他

第7章 日本の医薬品ろ過市場：技法別内訳

  • 精密濾過
  • 限外濾過
  • クロスフローろ過
  • ナノ濾過
  • その他

第8章 日本の医薬品ろ過市場：用途別内訳

  • 最終製品加工
  • 原材料の濾過
  • 細胞分離
  • 水の浄化
  • 空気清浄

第9章 日本の医薬品ろ過市場：事業規模別内訳

  • 製造規模
  • パイロットスケール
  • 研究開発規模

第10章 日本の医薬品ろ過市場：競合情勢

  • 概要
  • 市場構造
  • 市場プレーヤーのポジショニング
  • 主要成功戦略
  • 競合ダッシュボード
  • 企業評価象限

第11章 主要企業のプロファイル

第12章 日本の医薬品ろ過市場：業界分析

  • 促進要因・抑制要因・機会
  • ポーターのファイブフォース分析
  • バリューチェーン分析

第13章 付録

目次
Product Code: SR112024A19970

Japan pharmaceutical filtration market size reached US$ 720.8 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,388.3 Million by 2032, exhibiting a growth rate (CAGR) of 12.70% during 2024-2032. The implementation of stringent regulations by government bodies to ensure purity in the production of pharmaceuticals products is primarily driving the market growth.

Pharmaceutical filtration involves the elimination of undesired particles or contaminants from medical products or their production environments through diverse filtration techniques. The primary aim is to eradicate impurities like microorganisms, particulate matter, endotoxins, and other substances that could jeopardize the pharmaceuticals' integrity and purity. This process holds a pivotal role in guaranteeing the safety, quality, and efficacy of pharmaceutical products. It is applied at multiple stages throughout the drug manufacturing process, encompassing the purification of raw materials, processing of intermediate products, and the final filtration of the end product. The choice of filtration methods varies based on the specific requirements of the pharmaceuticals industry.

Japan Pharmaceutical Filtration Market Trends:

The Japan pharmaceutical filtration market is experiencing substantial growth, propelled by a significant upsurge in the biopharmaceutical industry. Concurrently, the escalating prevalence of chronic diseases among the population is contributing to market expansion. Besides this, the increasing demand for parenteral drugs, injectable formulations, and aseptic processing underscores the need for reliable sterile filtration solutions, thereby driving the demand for high-performance filters and filter media within the pharmaceuticals sector, which is acting as another significant growth-inducing factor. Moreover, ongoing technological advancements in filtration, characterized by improved filter designs, innovative filter media, and advanced membrane technologies, are fostering the adoption of cutting-edge filtration solutions. These advancements offer notable advantages, including reduced processing time, improved product yield, and enhanced cost-effectiveness. Furthermore, the growing emphasis on single-use technologies is a catalyst for market growth, given the associated benefits such as reduced cross-contamination risks, simplified validation processes, and improved operational efficiency. Additionally, the increased adoption of innovative treatment therapies, including therapeutic proteins, monoclonal antibodies, and vaccines, has led to heightened utilization of filtration systems by biotechnology and biopharmaceutical companies. The confluence of these factors will position the Japan pharmaceutical filtration market at the forefront of advancements in the healthcare and biopharmaceutical sectors in the coming years.

Japan Pharmaceutical Filtration Market Segmentation:

Product Insights:

  • Membrane Filters
  • MCE Membrane Filters
  • Coated Cellulose Acetate Membrane Filters
  • PTFE Membrane Filters
  • Nylon Membrane Filters
  • PVDF Membrane Filters
  • Others
  • Prefilters and Depth Media
  • Glass Fiber Filters
  • PTFE Fiber Filters
  • Single-use Systems
  • Cartridges and Capsules
  • Filter Holders
  • Filtration Accessories
  • Others

Technique Insights:

  • Microfiltration
  • Ultrafiltration
  • Crossflow Filtration
  • Nanofiltration
  • Others

Application Insights:

  • Final Product Processing
  • Active Pharmaceutical Ingredient Filtration
  • Sterile Filtration
  • Protein Purification
  • Vaccines and Antibody Processing
  • Formulation and Filling Solutions
  • Viral Clearance
  • Raw Material Filtration
  • Media Buffer
  • Pre-Filtration
  • Bioburden Testing
  • Cell Separation
  • Water Purification
  • Air Purification

Scale of Operation Insights:

  • Manufacturing Scale
  • Pilot-scale
  • Research and Development Scale

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Key Questions Answered in This Report:

  • How has the Japan pharmaceutical filtration market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Japan pharmaceutical filtration market?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of product?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of technique?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of application?
  • What is the breakup of the Japan pharmaceutical filtration market on the basis of scale of operation?
  • What are the various stages in the value chain of the Japan pharmaceutical filtration market?
  • What are the key driving factors and challenges in the Japan pharmaceutical filtration?
  • What is the structure of the Japan pharmaceutical filtration market and who are the key players?
  • What is the degree of competition in the Japan pharmaceutical filtration market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Japan Pharmaceutical Filtration Market - Introduction

  • 4.1 Overview
  • 4.2 Market Dynamics
  • 4.3 Industry Trends
  • 4.4 Competitive Intelligence

5 Japan Pharmaceutical Filtration Market Landscape

  • 5.1 Historical and Current Market Trends (2018-2023)
  • 5.2 Market Forecast (2024-2032)

6 Japan Pharmaceutical Filtration Market - Breakup by Product

  • 6.1 Membrane Filters
    • 6.1.1 Overview
    • 6.1.2 Historical and Current Market Trends (2018-2023)
    • 6.1.3 Market Segmentation
      • 6.1.3.1 MCE Membrane Filters
      • 6.1.3.2 Coated Cellulose Acetate Membrane Filters
      • 6.1.3.3 PTFE Membrane Filters
      • 6.1.3.4 Nylon Membrane Filters
      • 6.1.3.5 PVDF Membrane Filters
      • 6.1.3.6 Others
    • 6.1.4 Market Forecast (2024-2032)
  • 6.2 Prefilters and Depth Media
    • 6.2.1 Overview
    • 6.2.2 Historical and Current Market Trends (2018-2023)
    • 6.2.3 Market Segmentation
      • 6.2.3.1 Glass Fiber Filters
      • 6.2.3.2 PTFE Fiber Filters
    • 6.2.4 Market Forecast (2024-2032)
  • 6.3 Single-use Systems
    • 6.3.1 Overview
    • 6.3.2 Historical and Current Market Trends (2018-2023)
    • 6.3.3 Market Forecast (2024-2032)
  • 6.4 Cartridges and Capsules
    • 6.4.1 Overview
    • 6.4.2 Historical and Current Market Trends (2018-2023)
    • 6.4.3 Market Forecast (2024-2032)
  • 6.5 Filter Holders
    • 6.5.1 Overview
    • 6.5.2 Historical and Current Market Trends (2018-2023)
    • 6.5.3 Market Forecast (2024-2032)
  • 6.6 Filtration Accessories
    • 6.6.1 Overview
    • 6.6.2 Historical and Current Market Trends (2018-2023)
    • 6.6.3 Market Forecast (2024-2032)
  • 6.7 Others
    • 6.7.1 Historical and Current Market Trends (2018-2023)
    • 6.7.2 Market Forecast (2024-2032)

7 Japan Pharmaceutical Filtration Market - Breakup by Technique

  • 7.1 Microfiltration
    • 7.1.1 Overview
    • 7.1.2 Historical and Current Market Trends (2018-2023)
    • 7.1.3 Market Forecast (2024-2032)
  • 7.2 Ultrafiltration
    • 7.2.1 Overview
    • 7.2.2 Historical and Current Market Trends (2018-2023)
    • 7.2.3 Market Forecast (2024-2032)
  • 7.3 Crossflow Filtration
    • 7.3.1 Overview
    • 7.3.2 Historical and Current Market Trends (2018-2023)
    • 7.3.3 Market Forecast (2024-2032)
  • 7.4 Nanofiltration
    • 7.4.1 Overview
    • 7.4.2 Historical and Current Market Trends (2018-2023)
    • 7.4.3 Market Forecast (2024-2032)
  • 7.5 Others
    • 7.5.1 Historical and Current Market Trends (2018-2023)
    • 7.5.2 Market Forecast (2024-2032)

8 Japan Pharmaceutical Filtration Market - Breakup by Application

  • 8.1 Final Product Processing
    • 8.1.1 Overview
    • 8.1.2 Historical and Current Market Trends (2018-2023)
    • 8.1.3 Market Segmentation
      • 8.1.3.1 Active Pharmaceutical Ingredient Filtration
      • 8.1.3.2 Sterile Filtration
      • 8.1.3.3 Protein Purification
      • 8.1.3.4 Vaccines and Antibody Processing
      • 8.1.3.5 Formulation and Filling Solutions
      • 8.1.3.6 Viral Clearance
    • 8.1.4 Market Forecast (2024-2032)
  • 8.2 Raw Material Filtration
    • 8.2.1 Overview
    • 8.2.2 Historical and Current Market Trends (2018-2023)
    • 8.2.3 Market Segmentation
      • 8.2.3.1 Media Buffer
      • 8.2.3.2 Pre-Filtration
      • 8.2.3.3 Bioburden Testing
    • 8.2.4 Market Forecast (2024-2032)
  • 8.3 Cell Separation
    • 8.3.1 Overview
    • 8.3.2 Historical and Current Market Trends (2018-2023)
    • 8.3.3 Market Forecast (2024-2032)
  • 8.4 Water Purification
    • 8.4.1 Overview
    • 8.4.2 Historical and Current Market Trends (2018-2023)
    • 8.4.3 Market Forecast (2024-2032)
  • 8.5 Air Purification
    • 8.5.1 Overview
    • 8.5.2 Historical and Current Market Trends (2018-2023)
    • 8.5.3 Market Forecast (2024-2032)

9 Japan Pharmaceutical Filtration Market - Breakup by Scale of Operation

  • 9.1 Manufacturing Scale
    • 9.1.1 Overview
    • 9.1.2 Historical and Current Market Trends (2018-2023)
    • 9.1.3 Market Forecast (2024-2032)
  • 9.2 Pilot-scale
    • 9.2.1 Overview
    • 9.2.2 Historical and Current Market Trends (2018-2023)
    • 9.2.3 Market Forecast (2024-2032)
  • 9.3 Research and Development Scale
    • 9.3.1 Overview
    • 9.3.2 Historical and Current Market Trends (2018-2023)
    • 9.3.3 Market Forecast (2024-2032)

10 Japan Pharmaceutical Filtration Market - Competitive Landscape

  • 10.1 Overview
  • 10.2 Market Structure
  • 10.3 Market Player Positioning
  • 10.4 Top Winning Strategies
  • 10.5 Competitive Dashboard
  • 10.6 Company Evaluation Quadrant

11 Profiles of Key Players

  • 11.1 Company A
    • 11.1.1 Business Overview
    • 11.1.2 Product Portfolio
    • 11.1.3 Business Strategies
    • 11.1.4 SWOT Analysis
    • 11.1.5 Major News and Events
  • 11.2 Company B
    • 11.2.1 Business Overview
    • 11.2.2 Product Portfolio
    • 11.2.3 Business Strategies
    • 11.2.4 SWOT Analysis
    • 11.2.5 Major News and Events
  • 11.3 Company C
    • 11.3.1 Business Overview
    • 11.3.2 Product Portfolio
    • 11.3.3 Business Strategies
    • 11.3.4 SWOT Analysis
    • 11.3.5 Major News and Events
  • 11.4 Company D
    • 11.4.1 Business Overview
    • 11.4.2 Product Portfolio
    • 11.4.3 Business Strategies
    • 11.4.4 SWOT Analysis
    • 11.4.5 Major News and Events
  • 11.5 Company E
    • 11.5.1 Business Overview
    • 11.5.2 Product Portfolio
    • 11.5.3 Business Strategies
    • 11.5.4 SWOT Analysis
    • 11.5.5 Major News and Events

12 Japan Pharmaceutical Filtration Market - Industry Analysis

  • 12.1 Drivers, Restraints, and Opportunities
    • 12.1.1 Overview
    • 12.1.2 Drivers
    • 12.1.3 Restraints
    • 12.1.4 Opportunities
  • 12.2 Porters Five Forces Analysis
    • 12.2.1 Overview
    • 12.2.2 Bargaining Power of Buyers
    • 12.2.3 Bargaining Power of Suppliers
    • 12.2.4 Degree of Competition
    • 12.2.5 Threat of New Entrants
    • 12.2.6 Threat of Substitutes
  • 12.3 Value Chain Analysis

13 Appendix